Literature DB >> 8989683

Comparison of pharmacologic stress agents.

J A Leppo1.   

Abstract

In choosing a pharmacologic agent for stress testing, the clinician must keep a number of things in mind, such as the diagnostic utility of the agent or in what situations a vasodilator or catecholamine will be the better choice. Although all stress agents produce similar diagnostic accuracy for CAD, vasodilators have a higher cardiac uptake than catecholamines, and the addition of exercise improves the heart/background contrast ratios. With regard to physiologic comparisons, exercise or dobutamine will double coronary perfusion compared with baseline flow, but vasodilators produce a threefold or fourfold increase. The clinician should also keep in mind that adenosine will produce the shortest duration of hyperemia, whereas dobutamine and arbutamine produce a longer effect, and dipyridamole has the longest duration. If electrophysiologic considerations are important, exercise and catecholamines accelerate sinoatrial and atrioventricular conduction and are not typically associated with heart block. In contrast, adenosine can cause transient atrioventricular block, but this rarely occurs with dipyridamole. Clinical factors also must be considered. Although clinical utility of pharmacologic stress agents in the first 24 hours after infarction has not been demonstrated, the prognostic utility of vasodilators in the subsequent 2- to 4-day period has been shown. With patients with pulmonary disease (asthma) who do not have wheezing, dipyridamole can be used, but dobutamine or arbutamine should be used in patients with recent respiratory failure or bronchospasm before testing. In patients with left bundle branch block, vasodilators are the preferred stress agents rather than synthetic catecholamines or dynamic exercise. In the first crossover thallium imaging, there was good overall agreement in segmental perfusion comparing adenosine and dipyridamole, but there was a tendency for adenosine to detect more ischemia. The clinical significance (if any) for these findings has yet to be determined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989683     DOI: 10.1016/s1071-3581(96)90204-4

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  32 in total

Review 1.  Attenuation compensation for cardiac single-photon emission computed tomographic imaging: Part 2. Attenuation compensation algorithms.

Authors:  M A King; B M Tsui; T S Pan; S J Glick; E J Soares
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952

Review 2.  Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease.

Authors:  A S Iskandrian; M S Verani; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

3.  Conditions for vasodilator-induced coronary steal in experimental myocardial ischemia.

Authors:  L C Becker
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

Review 4.  Nuclear cardiology (2).

Authors:  B L Zaret; F J Wackers
Journal:  N Engl J Med       Date:  1993-09-16       Impact factor: 91.245

5.  Safety of dipyridamole testing in 73,806 patients: the Multicenter Dipyridamole Safety Study.

Authors:  J Lette; J L Tatum; S Fraser; D D Miller; D D Waters; G Heller; E B Stanton; H S Bom; J Leppo; S Nattel
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

6.  Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction.

Authors:  J A Leppo; J O'Brien; J A Rothendler; J D Getchell; V W Lee
Journal:  N Engl J Med       Date:  1984-04-19       Impact factor: 91.245

7.  Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events.

Authors:  K A Brown; J O'Meara; C E Chambers; D A Plante
Journal:  Am J Cardiol       Date:  1990-01-15       Impact factor: 2.778

8.  Dobutamine myocardial perfusion imaging.

Authors:  M S Verani
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

9.  Adenosine thallium-201 is superior to exercise thallium-201 for detecting coronary artery disease in patients with left bundle branch block.

Authors:  J H O'Keefe; T M Bateman; C S Barnhart
Journal:  J Am Coll Cardiol       Date:  1993-05       Impact factor: 24.094

Review 10.  Dipyridamole perfusion scintigraphy.

Authors:  E H Botvinick; M W Dae
Journal:  Semin Nucl Med       Date:  1991-07       Impact factor: 4.446

View more
  9 in total

1.  Patient preparation for nuclear imaging: when should anti-ischemic medications be withheld?

Authors:  Sarkis B Baghdasarian; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2007 Nov-Dec       Impact factor: 5.952

Review 2.  Nonacute coronary syndrome anginal chest pain.

Authors:  Megha Agarwal; Puja K Mehta; C Noel Bairey Merz
Journal:  Med Clin North Am       Date:  2010-03       Impact factor: 5.456

Review 3.  Myocardial blood flow quantification for evaluation of coronary artery disease by positron emission tomography, cardiac magnetic resonance imaging, and computed tomography.

Authors:  Alfonso H Waller; Ron Blankstein; Raymond Y Kwong; Marcelo F Di Carli
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

4.  Detection of moderate regional ischemia in pig hearts in vivo by near-infrared and thermal imaging: effects of dipyridamole.

Authors:  Valery V Kupriyanov; Darren M Manley; Bo Xiang
Journal:  Int J Cardiovasc Imaging       Date:  2007-04-13       Impact factor: 2.357

5.  Is coronary calcium scoring too late? Total body arterial calcium burden in patients without known CAD and normal MPI.

Authors:  Adel H A Allam; Randall C Thompson; Michael A Eskander; Mohamed A Mandour Ali; Ayman Sadek; Chris J Rowan; M Linda Sutherland; James D Sutherland; Bruno Frohlich; David E Michalik; Caleb E Finch; Jagat Narula; Gregory S Thomas; L Samuel Wann
Journal:  J Nucl Cardiol       Date:  2017-05-25       Impact factor: 5.952

6.  Inotropic stress with arbutamine is superior to vasodilator stress with dipyridamole for the detection of reversible ischemia with Tc-99m sestamibi single-photon emission computed tomography.

Authors:  P Soman; R Khattar; R Senior; A Lahiri
Journal:  J Nucl Cardiol       Date:  1997 Sep-Oct       Impact factor: 5.952

Review 7.  Noninvasive monitoring of medical therapy.

Authors:  Mark A Kudes; Ronald G Schwartz
Journal:  Curr Cardiol Rep       Date:  2006-03       Impact factor: 2.931

8.  Respiratory resistance of patients during cardiac stress testing with adenosine: is dyspnea a sign of bronchospasm?

Authors:  Eva Fricke; Elke Esdorn; Annett Kammeier; Harald Fricke; Rainer Preuss; Wolfgang Burchert; Oliver Lindner
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

9.  Update of the Brazilian Guideline on Nuclear Cardiology - 2020.

Authors:  Luiz Eduardo Mastrocola; Barbara Juarez Amorim; João Vicente Vitola; Simone Cristina Soares Brandão; Gabriel Blacher Grossman; Ronaldo de Souza Leão Lima; Rafael Willain Lopes; William Azem Chalela; Lara Cristiane Terra Ferreira Carreira; José Roberto Nolasco de Araújo; Cláudio Tinoco Mesquita; José Claudio Meneghetti
Journal:  Arq Bras Cardiol       Date:  2020-02       Impact factor: 2.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.